Veitonmaki N - Search Results

1

Gene transfer of kringle 1-5 suppresses tumor development and improves prognosis of mice with hepatocellular carcinoma.

Torimura T, Ueno T, Kin M, Taniguchi E, Nakamura T, Inoue K, Sakata R, Hashimoto O, Sakamoto M, Ohira H, Kumashiro R, Sata M, Yano H, Kojiro M, Veitonmaki N, Cao Y. Torimura T, et al. Among authors: veitonmaki n. Gastroenterology. 2006 Apr;130(4):1301-10. doi: 10.1053/j.gastro.2006.02.020. Gastroenterology. 2006. PMID: 16618420

2

Kringle structures and antiangiogenesis.

Cao Y, Cao R, Veitonmäki N. Cao Y, et al. Among authors: veitonmaki n. Curr Med Chem Anticancer Agents. 2002 Nov;2(6):667-81. doi: 10.2174/1568011023353705. Curr Med Chem Anticancer Agents. 2002. PMID: 12678719 Review.

3

Endothelial cell surface ATP synthase-triggered caspase-apoptotic pathway is essential for k1-5-induced antiangiogenesis.

Veitonmäki N, Cao R, Wu LH, Moser TL, Li B, Pizzo SV, Zhivotovsky B, Cao Y. Veitonmäki N, et al. Cancer Res. 2004 May 15;64(10):3679-86. doi: 10.1158/0008-5472.CAN-03-1754. Cancer Res. 2004. PMID: 15150128

4

Suppression of angiogenesis and tumor growth by the inhibitor K1-5 generated by plasmin-mediated proteolysis.

Cao R, Wu HL, Veitonmäki N, Linden P, Farnebo J, Shi GY, Cao Y. Cao R, et al. Among authors: veitonmaki n. Proc Natl Acad Sci U S A. 1999 May 11;96(10):5728-33. doi: 10.1073/pnas.96.10.5728. Proc Natl Acad Sci U S A. 1999. PMID: 10318952 Free PMC article.

5

Adiponectin-induced antiangiogenesis and antitumor activity involve caspase-mediated endothelial cell apoptosis.

Bråkenhielm E, Veitonmäki N, Cao R, Kihara S, Matsuzawa Y, Zhivotovsky B, Funahashi T, Cao Y. Bråkenhielm E, et al. Among authors: veitonmaki n. Proc Natl Acad Sci U S A. 2004 Feb 24;101(8):2476-81. doi: 10.1073/pnas.0308671100. Proc Natl Acad Sci U S A. 2004. PMID: 14983034 Free PMC article.

6

Immortalization of bovine capillary endothelial cells by hTERT alone involves inactivation of endogenous p16INK4A/pRb.

Veitonmäki N, Fuxe J, Hultdin M, Roos G, Pettersson RF, Cao Y. Veitonmäki N, et al. FASEB J. 2003 Apr;17(6):764-6. doi: 10.1096/fj.02-0599fje. Epub 2003 Feb 5. FASEB J. 2003. PMID: 12586745

7

A DNA vaccine targeting angiomotin inhibits angiogenesis and suppresses tumor growth.

Holmgren L, Ambrosino E, Birot O, Tullus C, Veitonmäki N, Levchenko T, Carlson LM, Musiani P, Iezzi M, Curcio C, Forni G, Cavallo F, Kiessling R. Holmgren L, et al. Among authors: veitonmaki n. Proc Natl Acad Sci U S A. 2006 Jun 13;103(24):9208-13. doi: 10.1073/pnas.0603110103. Epub 2006 Jun 5. Proc Natl Acad Sci U S A. 2006. PMID: 16754857 Free PMC article.

8

Elevated levels of urine angiostatin and plasminogen/plasmin in cancer patients.

Cao Y, Veitonmaki N, Keough K, Cheng H, Lee LS, Zurakowski D. Cao Y, et al. Among authors: veitonmaki n. Int J Mol Med. 2000 May;5(5):547-51. doi: 10.3892/ijmm.5.5.547. Int J Mol Med. 2000. PMID: 10762660

9

Therapeutic antibodies targeting angiomotin inhibit angiogenesis in vivo.

Levchenko T, Veitonmäki N, Lundkvist A, Gerhardt H, Ming Y, Berggren K, Kvanta A, Carlsson R, Holmgren L. Levchenko T, et al. Among authors: veitonmaki n. FASEB J. 2008 Mar;22(3):880-9. doi: 10.1096/fj.07-9509com. Epub 2007 Nov 5. FASEB J. 2008. PMID: 17984175

10

Differential roles of p80- and p130-angiomotin in the switch between migration and stabilization of endothelial cells.

Ernkvist M, Birot O, Sinha I, Veitonmaki N, Nyström S, Aase K, Holmgren L. Ernkvist M, et al. Among authors: veitonmaki n. Biochim Biophys Acta. 2008 Mar;1783(3):429-37. doi: 10.1016/j.bbamcr.2007.11.018. Epub 2007 Dec 8. Biochim Biophys Acta. 2008. PMID: 18164266 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

19 results

Search Page

Filters